Scynexis Inc. (SCYX) intrinsic value & 10-year financials

Scynexis Inc. (SCYX) has a Graham intrinsic value of $46.17 per share. At $3.67 on Oct 17, 2026, the stock trades 92% below that value. Over the last 10 fiscal years revenue grew 62.8% a year to $20.6M, with an average return on invested capital of 676.8%.

Graham intrinsic value
$46.17
Share price (Oct 17, 2026)
$3.67
Price vs Graham value
92% below
Market cap
$183.3M
Revenue (FY2025)
$20.6M
Revenue growth (10-yr CAGR)
62.8%
ROIC (10-yr avg)
676.8%
Free cash flow (FY2025)
—

SCYX 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $20.6M -$8.6M -$0.17 — -78.0% -45.3%
FY2024 $3.7M -$21.3M -$0.44 — -990.8% -89.8%
FY2023 $140.1M $67.0M $1.39 — 51.9% 7912.7%
FY2022 $5.1M -$62.8M -$1.47 — -1684.5% 244.4%
FY2021 $13.2M -$32.9M -$1.25 — -462.2% 120.1%
FY2020 $0 -$55.2M — -$49.4M — 104.4%
FY2019 $121.0K -$53.7M — — -40430.6% -1067.1%
FY2018 $257.0K -$12.5M — -$28.9M -11666.5% -65.5%
FY2017 $257.0K -$25.1M — -$24.6M -10241.2% -138.5%
FY2016 $257.0K -$30.0M -$1.58 -$29.4M -10823.7% -207.4%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

SCYNEXIS INC is a consistent compounder, expanding top-line revenue at 62.8% annually over the past decade.

SCYNEXIS INC has historically struggled to out-earn its cost of capital, averaging just -4.6% ROIC.

SCYNEXIS INC has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, SCYNEXIS INC is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $46.17 per share.

SCYX stock: frequently asked questions

What is the intrinsic value of Scynexis Inc. (SCYX) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 15.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, SCYX's intrinsic value is about $46.17 per share.

Is SCYX stock undervalued?

At $3.67 (close on Oct 17, 2026), SCYX trades 92% below its Graham value of $46.17. On Graham's terms that leaves a margin of safety. A formula is a starting point for research, not a recommendation.

How fast has Scynexis Inc. grown?

Revenue went from $257.0K in fiscal 2016 to $20.6M in fiscal 2025, a compound annual growth rate of 62.8%. Net income was -$8.6M in fiscal 2025.

What is SCYX's return on invested capital?

Average ROIC over the last 10 fiscal years was 676.8%, and average return on equity was -103.5%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this SCYX data come from?

From Scynexis Inc.'s annual 10-K filings on SEC EDGAR, most recently filed Aug 10, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar pharmaceutical preparations stocks